omega-n-methylarginine has been researched along with Uterine Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hitsumoto, Y; Kitagawa, H; Matsuura, S; Saheki, S; Yano, J | 1 |
| Buralli, S; Gennazzani, A; Ghiadoni, L; Lombardo, M; Petraglia, F; Pinto, S; Salvetti, A; Taddei, S; Virdis, A | 1 |
2 other study(ies) available for omega-n-methylarginine and Uterine Neoplasms
| Article | Year |
|---|---|
Attenuation of human chorionic gonadotropin release by nitric oxide in choriocarcinoma cell lines.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Arginine; Blotting, Western; Choriocarcinoma; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Hemoglobin A; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured; Uterine Neoplasms | 1996 |
Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women.
Topics: Acetylcholine; Adult; Arginine; Ascorbic Acid; Blood Pressure; Cardiovascular Agents; Endothelium, Vascular; Enzyme Inhibitors; Estrogen Replacement Therapy; Estrogens; Female; Forearm; Humans; Indomethacin; Leiomyoma; Middle Aged; omega-N-Methylarginine; Ovariectomy; Postoperative Period; Reference Values; Regional Blood Flow; Uterine Neoplasms; Vasodilation; Vasodilator Agents | 2000 |